Clincosm LogoSign in Get a demo

Geographic Atrophy

Showing 26 - 50 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Completed
  • Geographic Atrophy
  • Macular Degeneration
  • Phoenix, Arizona
  • +77 more
Mar 17, 2022

Geographic Atrophy, Age Related Macular Degeneration, AMD Trial in Somerville (ALK-001 oral capsule, Placebo oral capsule)

Active, not recruiting
  • Geographic Atrophy
  • +3 more
  • ALK-001 oral capsule
  • Placebo oral capsule
  • Somerville, Massachusetts
    Coordinating Center
Feb 15, 2022

High Resolution Retinal Imaging

Recruiting
  • Stargardts
  • +4 more
  • Retinal imaging
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 26, 2022

Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease Trial in United Kingdom, United States (GT005)

Recruiting
  • Dry Age-related Macular Degeneration
  • +6 more
  • GT005
  • Saint Petersburg, Florida
  • +12 more
Dec 21, 2021

Geographic Atrophy Trial in United States (PEGCETACOPLAN (APL-2))

Completed
  • Geographic Atrophy
  • PEGCETACOPLAN (APL-2)
  • Bakersfield, California
  • +4 more
Nov 8, 2021

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Active, not recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Beverly Hills, California
  • +208 more
Sep 14, 2021

Geographic Atrophy Trial in United States (NGM621, Sham Comparator)

Active, not recruiting
  • Geographic Atrophy
  • NGM621
  • Sham Comparator
  • Phoenix, Arizona
  • +64 more
Aug 19, 2021

Geographic Atrophy Trial in Melbourne (ONL1204 Ophthalmic solution, sham injection)

Recruiting
  • Geographic Atrophy
  • ONL1204 Ophthalmic solution
  • sham injection
  • Melbourne, Victoria, Australia
    Center for Eye Rearch Australia
Jul 29, 2021

Age-Related Macular Degeneration, Geographic Atrophy Trial run by the NEI (Sirolimus)

Completed
Has Results
  • Age-Related Macular Degeneration
  • Geographic Atrophy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 14, 2021

Dry Age-related Macular Degeneration, Geographic Atrophy, Gene Therapy Trial (Intravitreal AAVCAGsCD59, Intravitreal Sham

Withdrawn
  • Dry Age-related Macular Degeneration
  • +3 more
  • Intravitreal AAVCAGsCD59
  • Intravitreal Sham Injection
  • (no location specified)
May 6, 2021

Natural Progression of Dry Age-related Macular Degeneration

Recruiting
  • Dry Age-related Macular Degeneration
  • +5 more
    • Phoenix, Arizona
    • +65 more
    Feb 22, 2021

    Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

    Completed
    • Dry Age-related Macular Degeneration
    • +4 more
    • GEM103
    • Phoenix, Arizona
    • +11 more
    Feb 9, 2021

    Geographic Atrophy, Age-related Macular Degeneration Trial in United States (LFG316, Sham, LFG316 Lower dose)

    Completed
    Has Results
    • Geographic Atrophy
    • Age-related Macular Degeneration
    • Phoenix, Arizona
    • +18 more
    Dec 9, 2020

    Geographic Atrophy Trial in Australia, New Zealand, United States (Pegcetacoplan, Sham Procedure)

    Completed
    Has Results
    • Geographic Atrophy
    • Mobile, Alabama
    • +45 more
    Sep 14, 2020

    Geographic Atrophy Trial in United States (NGM621)

    Completed
    • Geographic Atrophy
    • NGM621
    • Arcadia, California
    • +5 more
    Sep 29, 2020

    Geographic Atrophy, Age-Related Macular Degeneration, AMD Trial run by the CC (OT-551 antioxidant eye drop)

    Completed
    Has Results
    • Geographic Atrophy
    • +2 more
    • OT-551 antioxidant eye drop
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 6, 2020

    Visual Acuity, Geographic Atrophy, Macular Degeneration Trial in United States (CNTO 2476 3.0 x 10^5 cells, Subretinal Delivery

    Completed
    Has Results
    • Visual Acuity
    • +2 more
    • CNTO 2476 3.0 x 10^5 cells
    • Subretinal Delivery System
    • Arcadia, California
    • +7 more
    Jun 2, 2020

    Dry Macular Degeneration, Geographic Atrophy Trial in United States (CPCB-RPE1)

    Active, not recruiting
    • Dry Macular Degeneration
    • Geographic Atrophy
    • CPCB-RPE1
    • Phoenix, Arizona
    • +5 more
    May 27, 2020

    Age-Related Macular Degeneration, Geographic Atrophy, Reticular Pseudodrusen Trial in Milan (Subthreshold 577 nm yellow

    Completed
    Has Results
    • Age-Related Macular Degeneration
    • +2 more
    • Subthreshold 577 nm yellow wavelength laser photo-coagulator
    • Milan, MI, Italy
      Ospedale San Raffaele
    Feb 2, 2020

    Geographic Atrophy Trial in United States (RO7171009)

    Completed
    • Geographic Atrophy
    • Bakersfield, California
    • +12 more
    Feb 10, 2020

    Geographic Atrophy Trial in Worldwide (Lampalizumab, Sham Comparator)

    Terminated
    Has Results
    • Geographic Atrophy
    • Phoenix, Arizona
    • +152 more
    Oct 14, 2019

    Geographic Atrophy Trial in United States (Sham, Lampalizumab)

    Completed
    Has Results
    • Geographic Atrophy
    • Mesa, Arizona
    • +35 more
    Sep 23, 2019

    Geographic Atrophy, Age-related Macular Degeneration Trial in Barcelona (Micropulse)

    Completed
    • Geographic Atrophy
    • Age-related Macular Degeneration
    • Micropulse
    • Barcelona, Spain
      Institut de la màcula i de la retina
    Sep 16, 2019

    Geographic Atrophy Trial in Germany, United States (Lampalizumab)

    Terminated
    Has Results
    • Geographic Atrophy
    • Tucson, Arizona
    • +45 more
    Sep 10, 2019

    Geographic Atrophy Secondary to Age-Related Macular Degeneration

    Terminated
    • Geographic Atrophy
    • No intervention
    • Springdale, Arkansas
    • +90 more
    Aug 16, 2019